Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.
Ozyerli-Goknar E. et al, (2023), Cell commun signal, 21
Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survival
Ozyerli-Goknar E. et al, (2022)
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities.
Yedier-Bayram O. et al, (2022), Cell death dis, 13
Overcoming chemoresistance in triple negative breast cancer by bromodomain inhibition
Yedier-Bayram O. et al, (2022), European journal of cancer, 174, S69 - S69
A micropillar-based microfluidic viscometer for Newtonian and non-Newtonian fluids.
Mustafa A. et al, (2020), Anal chim acta, 1135, 107 - 115
Nesprin-1 impact on tumorigenic cell phenotypes.
Sur-Erdem I. et al, (2020), Mol biol rep, 47, 921 - 934
Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma.
Senbabaoglu F. et al, (2020), Front neurosci, 14
Differential effects of adenylyl cyclase-protein kinase A cascade on shear-induced changes of sickle cell deformability.
Ugurel E. et al, (2019), Clin hemorheol microcirc, 73, 531 - 543
From Experiments to Simulation: Shear-Induced Responses of Red Blood Cells to Different Oxygen Saturation Levels.
Ugurel E. et al, (2019), Front physiol, 10
Nitrite may serve as a combination partner and a biomarker for the anti-cancer activity of RRx-001.
Cirrik S. et al, (2019), Biorheology, 56, 221 - 235
Bringing Packed Red Blood Cells to the Point of Combat Injury: Are We There Yet?
Ünlü A. et al, (2018), Turk j haematol, 35, 185 - 191